Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MIMEDX GROUP, INC.
Report date June 20, 2019 · Filed June 21, 2019
Section 16 reporting ended · disclosed 2019-06-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 181,545 |
Reported balance
After 2019-06-20 transaction · row 1
1 source rowRow 1 · 2019-06-20 · Exercise / conversion · Acquired 50,000 · Balance 181,545 F1: This transaction represents the exercise of a previously-issued stock option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.70 · Expires 2019-09-23 | Direct | 0 |
Reported balance
After 2019-06-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-06-20 · Exercise / conversion · Disposed 50,000 · Balance 0 F1: This transaction represents the exercise of a previously-issued stock option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2021-12-14 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2019-06-20 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 15,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.94 · Expires 2022-10-31 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2019-06-20 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 15,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.28 · Expires 2024-07-28 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2019-06-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 15,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.60 · Expires 2023-05-09 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2019-06-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 15,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents the exercise of a previously-issued stock option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2019 Filed Jun 21, 2019 19:10 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Exercise / conversionStock Option · Derivative | 50,000 | $0.70 Strike: $0.70 | $35,000.00 |
DisclosureSEC source: 0001376339-19-000025 · wf-form4_156114421121943.xml · derivative · entry 2 BLESER JOSEPH G · CIK 0001206574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2019-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction represents the exercise of a previously-issued stock option. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 19:10 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Exercise / conversionCommon Stock | 50,000 | $0.70 | $35,000.00 |
DisclosureSEC source: 0001376339-19-000025 · wf-form4_156114421121943.xml · nonDerivative · entry 1 BLESER JOSEPH G · CIK 0001206574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction represents the exercise of a previously-issued stock option. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:15 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 12,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-17-000097 · wf-form4_149522492107592.xml · nonDerivative · entry 1 BLESER JOSEPH G · CIK 0001206574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,545 F1 · shares: Grant of restricted stock which vests in full on the first anniversary date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.